Guidelines in development

ESCMID works throughout the year to propose and endorse quality guidelines to members and the global professional community. Below is a list of guidance documents that are currently under development. Explore the details of each guidance document and follow the evolution of their progress via the links provided.

The status of each project is defined based on the steps of the GIN-McMaster Guideline Development Checklist available here.

Title

Chair

Approval Date

Status

Website

Approach to suspected antibiotic allergy

Mark de Boer, Netherlands

January 2023

Data extraction (Completed)

Get to know more

Vaccination of the immunocompromised host

Olivier Epaulard, France

January 2023

Data extraction (Ongoing)

Get to know more

Dosing of antimicrobials in patients with renal impairment with or without RRT

Thomas Tängdén, Sweden

January 2023

Screening of literature (Ongoing)

Get to know more

OPENING Project: IncOrPorating Ethics iN ClINical Guidelines: Practical Indications

Elda Righi, Italy

October 2022

Summarising evidence and conclusions (Ongoing)

Get to know more

ESCMID Consensus document for management of COVID-19 in immunocompromised patients

Michele Bartoletti, Italy and Roy Chemaly, United States

May 2022

Summarising evidence and conclusions (Ongoing)

Get to know more

Update of the 2014 ESCMID guidelines for the management of the infection prevention & control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

Evelina Tacconelli, Italy

December 2020

Screening of literature (Ongoing)

Get to know more

Influenza management and treatment

Barbara Rath, France

December 2019

Data extraction (March 2024)

Get to know more

Microbiological diagnosis of bloodstream infections (ESCMID/ESA)

Brigitte Lamy, France

November 2018

Developing Recommendations and Determining their Strength (EtDs) (March 2024)

Get to know more

Management of uncomplicated urinary tract infections (IDSA/ESCMID)

Angela Huttner, Switzerland (ESCMID representative)

April 2018

Reporting and peer review (March 2024)

 

Diagnosis and management of infective encephalitis (ESCMID/EAN)

Thomas Whitfield, United States (ESCMID representative)

April 2018

Data extraction/quality assessment (April 2023)

 

Management of Staphylococcus aureus bacteremia (IDSA/ESCMID)

Winfried Kern, Germany and François Vandenesch, France

January 2017

Developing Recommendations and Determining their Strength (EtDs) (March 2024)

 

View more
View less

Currently there are no documents under public consultation.